Timed sequential chemotherapy with concomitant Granulocyte Colony-Stimulating Factor for high-risk acute myelogenous leukemia: a single arm clinical trial

BACKGROUND: The timed-sequential chemotherapy regimen consisting of etoposide, mitoxantrone and cytarabine (EMA) is an effective therapy for relapsed or refractory acute myelogenous leukemia (AML). We postulated that granulocyte colony-stimulating factor (G-CSF) might enhance the cytotoxicity of EMA...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xing-Yue, Elson, Paul, Pohlman, Brad, Lichtin, Alan, Hussein, Mohamad, Andresen, Steve, Kalaycio, Matt
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC113260/
https://www.ncbi.nlm.nih.gov/pubmed/12019034
http://dx.doi.org/10.1186/1471-2407-2-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC113260/
https://www.ncbi.nlm.nih.gov/pubmed/12019034
http://dx.doi.org/10.1186/1471-2407-2-12

Ejemplares similares